http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107058471-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate | 2016-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107058471-B |
| titleOfInvention | Kit for joint prediction of acute mountain sickness incidence risk through four microRNA biomarkers |
| abstract | The invention relates to a microRNA marker for detecting a person susceptible to acute mountain sickness and application of the microRNA marker in preparation of a kit for predicting the onset risk of the acute mountain sickness. microRNA markers consist of: microRNA-369-3p, microRNA-449b-3p, microRNA-136-3p and microRNA-4791. The invention mainly detects the 4 microRNA molecules in human protoplasm by adopting methods such as real-time fluorescence quantitative PCR and the like, and predicts the risk of acute mountain sickness by the expression level. The four microRNA markers are all suitable for screening large-scale acute mountain sickness susceptible persons on plain, and the sensitivity and specificity of combined application are obviously superior to those of single use. |
| priorityDate | 2016-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 85.